Source: Republic of China Taiwan
Taiwan’s medical prowess in smart healthcare has once again captured international attention at HIMSS 2026, one of the world’s premier health information and technology conferences. The Department of Industrial Technology (DoIT) under the Ministry of Economic Affairs (MOEA), in collaboration with the National Science and Technology Council (NSTC), led a delegation of 25 leading companies and research institutes to form the “Taiwan Smart Healthcare National Team.” Breaking away from the traditional single-device sales model, Taiwan presented–for the first time–a comprehensive “Total Care Solution” approach. The delegation showcased 29 cutting-edge technologies, successfully initiating clinical validation partnerships with five leading North American academic medical centres and eldercare institutions, including UCLA, USC, and Cedars-Sinai. This achievement signifies Taiwan’s transition from the development of isolated technologies to integrated systems that are “deployable and commercially viable.” Moreover, the integration also accelerated the introduction of new solutions into the North American market, further strengthening Taiwan’s key position in the global smart healthcare supply chain.
During this exhibition, the MOEA’s focus on “industrial deployment” and the NSTC’s commitment to “academic and research innovations” worked in synergy, enabling Taiwan to build a unique translational model “integrating semiconductor chips, ICT platforms, and hospital-based clinical validation.” By linking R&D, validation, and real-world application, Taiwan has enabled AI diagnostics and telemedicine solutions to move beyond laboratory data. These technologies are now being deployed in North America’s elderly communities and scenes of medical emergency, transforming them into practical, real-world healthcare tools.